These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36971558)

  • 1. Salvage Treatment of Refractory HSV Oral Lesions with Pritelivir in Allogeneic Hematopoietic Cell Transplant Recipients.
    Bosetti D; Bernardi C; Maulini M; Giannotti F; Mamez AC; Masouridi-Levrat S; Chalandon Y; Neofytos D
    Antimicrob Agents Chemother; 2023 Apr; 67(4):e0173222. PubMed ID: 36971558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case Commentary: "Salvage Treatment of Refractory HSV Oral Lesions with Pritelivir in Allogeneic Hematopoietic Cell Transplant Recipients" by Bosetti et al.
    Srinivasan K; Ho DY
    Antimicrob Agents Chemother; 2023 May; 67(5):e0027623. PubMed ID: 37014226
    [No Abstract]   [Full Text] [Related]  

  • 3. Delay of alternative antiviral therapy and poor outcomes of acyclovir-resistant herpes simplex virus infections in recipients of allogeneic stem cell transplant - a retrospective study.
    Ariza-Heredia EJ; Chemaly RF; Shahani LR; Jang Y; Champlin RE; Mulanovich VE
    Transpl Int; 2018 Jun; 31(6):639-648. PubMed ID: 29464765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of pritelivir and acyclovir in the treatment of herpes simplex virus infections in a mouse model of herpes simplex encephalitis.
    Quenelle DC; Birkmann A; Goldner T; Pfaff T; Zimmermann H; Bonsmann S; Collins DJ; Rice TL; Prichard MN
    Antiviral Res; 2018 Jan; 149():1-6. PubMed ID: 29113740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amenamevir for treating acyclovir-resistant or refractory herpes simplex virus infection in allogeneic hematopoietic stem cell transplantation recipients: Two case reports.
    Sallée L; Souchet L; Boutolleau D; Nguyen S
    Int J Antimicrob Agents; 2024 Jun; 63(6):107169. PubMed ID: 38608846
    [No Abstract]   [Full Text] [Related]  

  • 6. Acyclovir-resistant herpes simplex virus 1 infection early after allogeneic hematopoietic stem cell transplantation with T-cell depletion.
    Akahoshi Y; Kanda J; Ohno A; Komiya Y; Gomyo A; Hayakawa J; Harada N; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kimura SI; Kikuchi M; Nakasone H; Kako S; Shiraki K; Kanda Y
    J Infect Chemother; 2017 Jul; 23(7):485-487. PubMed ID: 28262533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges of aciclovir-resistant HSV infection in allogeneic bone marrow transplant recipients.
    Anton-Vazquez V; Mehra V; Mbisa JL; Bradshaw D; Basu TN; Daly ML; Mufti GJ; Pagliuca A; Potter V; Zuckerman M
    J Clin Virol; 2020 Jul; 128():104421. PubMed ID: 32417677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection due to acyclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Venard V; Dauendorffer JN; Carret AS; Corsaro D; Edert D; Bordigoni P; Le Faou A
    Pathol Biol (Paris); 2001 Sep; 49(7):553-8. PubMed ID: 11642018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the Emergence of Acyclovir-Resistant Herpes Simplex Virus Type 1 With Prognosis in Hematopoietic Stem Cell Transplantation Patients.
    Kakiuchi S; Tsuji M; Nishimura H; Yoshikawa T; Wang L; Takayama-Ito M; Kinoshita H; Lim CK; Fujii H; Yamada S; Harada S; Oka A; Mizuguchi M; Taniguchi S; Saijo M
    J Infect Dis; 2017 Mar; 215(6):865-873. PubMed ID: 28453848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of refractory acyclovir-resistant herpes simplex virus type 1 infection by continuous acyclovir administration.
    Ikawa Y; Fujiki T; Nishimura R; Noguchi K; Koshino E; Fujiki A; Fukuda M; Kuroda R; Mase S; Araki R; Maeba H; Shiraki K; Yachie A
    J Infect Chemother; 2019 Jan; 25(1):65-67. PubMed ID: 30064949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of pritelivir in refractory aciclovir-resistant herpes simplex virus type 2.
    Cannon L; Tholouli E; Ward C; Farooq H; Kingston M
    Int J STD AIDS; 2021 Sep; 32(10):978-980. PubMed ID: 33947276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of acyclovir-resistant herpes simplex virus with continuous infusion of high-dose acyclovir in hematopoietic cell transplant patients.
    Kim JH; Schaenman JM; Ho DY; Brown JM
    Biol Blood Marrow Transplant; 2011 Feb; 17(2):259-64. PubMed ID: 20615475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation.
    Chen Y; Scieux C; Garrait V; Socié G; Rocha V; Molina JM; Thouvenot D; Morfin F; Hocqueloux L; Garderet L; Espérou H; Sélimi F; Devergie A; Leleu G; Aymard M; Morinet F; Gluckman E; Ribaud P
    Clin Infect Dis; 2000 Oct; 31(4):927-35. PubMed ID: 11049772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual oral presentation of acyclovir-resistant herpes simplex in an allogeneic haematopoietic stem cell transplant recipient.
    Saunsbury T; Harte M; Ion D
    BMJ Case Rep; 2021 Dec; 14(12):. PubMed ID: 34969809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful clearance of cutaneous acyclovir-resistant, foscarnet-refractory herpes virus lesions with topical cidofovir in an allogeneic hematopoietic stem cell transplant patient.
    Muluneh B; Dean A; Armistead P; Khan T
    J Oncol Pharm Pract; 2013 Jun; 19(2):181-5. PubMed ID: 22635417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences: A Randomized Clinical Trial.
    Wald A; Timmler B; Magaret A; Warren T; Tyring S; Johnston C; Fife K; Selke S; Huang ML; Stobernack HP; Zimmermann H; Corey L; Birkmann A; Ruebsamen-Schaeff H
    JAMA; 2016 Dec; 316(23):2495-2503. PubMed ID: 27997653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical Treatment of Acyclovir-Resistant Herpes Simplex Virus Stomatitis after Allogeneic Hematopoietic Cell Transplantation.
    Heidenreich D; Kreil S; Mueller N; Jawhar M; Nolte F; Hofmann WK; Klein SA
    Oncol Res Treat; 2020; 43(12):672-678. PubMed ID: 33070144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus disease after allogeneic hematopoietic stem cell transplantation.
    Kawamura K; Wada H; Yamasaki R; Ishihara Y; Sakamoto K; Ashizawa M; Sato M; Machishima T; Terasako K; Kimura SI; Kikuchi M; Nakasone H; Yamazaki R; Kanda J; Kako S; Tanihara A; Nishida J; Kanda Y
    Transpl Infect Dis; 2013 Oct; 15(5):457-65. PubMed ID: 23895431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to antiviral drugs in herpes simplex virus infections among allogeneic stem cell transplant recipients: risk factors and prognostic significance.
    Chakrabarti S; Pillay D; Ratcliffe D; Cane PA; Collingham KE; Milligan DW
    J Infect Dis; 2000 Jun; 181(6):2055-8. PubMed ID: 10837192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience.
    El-Haddad D; El Chaer F; Vanichanan J; Shah DP; Ariza-Heredia EJ; Mulanovich VE; Gulbis AM; Shpall EJ; Chemaly RF
    Antiviral Res; 2016 Oct; 134():58-62. PubMed ID: 27582067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.